| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2413976
Max Phase: Preclinical
Molecular Formula: C18H14N2O5
Molecular Weight: 338.32
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COC(=O)c1ccc2c(c1)[n+]([O-])c(C(=O)c1ccccc1)c(C)[n+]2[O-]
Standard InChI: InChI=1S/C18H14N2O5/c1-11-16(17(21)12-6-4-3-5-7-12)20(24)15-10-13(18(22)25-2)8-9-14(15)19(11)23/h3-10H,1-2H3
Standard InChI Key: WOAQOBXIEODEOU-UHFFFAOYSA-N
Associated Targets(non-human)
Entamoeba histolytica 2676 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 338.32 | Molecular Weight (Monoisotopic): 338.0903 | AlogP: 1.43 | #Rotatable Bonds: 3 |
| Polar Surface Area: 97.25 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 0.74 | CX LogP: 1.18 | CX LogD: 1.18 |
| Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.31 | Np Likeness Score: -0.25 |
References
| 1. Duque-Montaño BE, Gómez-Caro LC, Sanchez-Sanchez M, Monge A, Hernández-Baltazar E, Rivera G, Torres-Angeles O.. (2013) Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica., 21 (15): [PMID:23787289] [10.1016/j.bmc.2013.05.036] |
Source
Source(1):